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Introduction
South Africa has the fastest-growing human immunodefi-
ciency virus (HIV)/acquired immune deficiency syndrome 
(AIDS) pandemic in sub-Saharan Africa. There is an average 
prevalence rate of 10.8% among the general population.1 
Despite the availability for several years of antiretroviral 
therapy (ART), commencement of the national dissemina-
tion of antiretroviral treatment to South African patients has 
been very recent. While the national distribution is an im-
portant public healthcare measure in South Africa, the mere 
availability of treatment is insufficient for patients to make 
gains in terms of their health status. Retention of patients in 
care and treatment adherence are important dimensions of 
therapeutic success. 
Poor adherence to ART is highly predictive of viral load 
and drug resistance.2 Therefore, it might have serious 
implications for the control of symptoms, recovery time, 
quality of life and mortality among HIV-infected persons. 
Moreover, poor adherence might lead to the development 
of drug-resistant strains of HIV, resulting in resistance 
to treatment and the need for more expensive second-
line medication.3 Considerable wastage is likely when 
resources are directed at medical consultations, purchase 
of medication, transport to appointments and other aspects 
surrounding medical care, if adherence to the treatment 
remains low. For these reasons, retention of patients in care 
and adherence to ART are of considerable importance. A 
high level of adherence to treatment is required for optimal 
effectiveness and the prevention of drug-resistant strains of 
HIV.4 
According to Hardon et al,5 pooled data from samples 
of patients in several African countries indicated that 
77% achieved adequate levels of adherence. Yet, much 
of these data were collected in experimental settings in 
which patients were required to meet specific criteria 
before enrolling, such as disclosure of their HIV status to at 
least one other individual. Studies conducted in resource-
constrained contexts suggestive of high adherence levels 
mainly relied on self-reported adherence, which was often 
unreliable, tracked small numbers of patients over short 
periods of time, or were conducted cross-sectionally so 
that adherence over time could not be assessed.6 In their 
Abstract 
Background: The effectiveness of antiretroviral therapy (ART) and the importance of adherence to treatment regimens are 
widely known. Yet, suboptimal adherence to ART and retention in care of patients still persists and, by many accounts, is 
fairly widespread. The aim of this study was to identify the structural barriers that influenced adherence among patients who 
were enrolled in the national ART programme in South Africa. 
Method: In this qualitative study, semi-structured interviews were conducted with a sample of 10 patients receiving ART at 
a public hospital in South Africa. 
Results: The results of the interviews were categorised according to poverty-related, institution-related and social barriers 
to clinic attendance and pill-taking, which collectively formed the structural barriers to adherence. The chief structural 
barriers to clinic attendance were time away from work, transport expenses, long waiting times and negative experiences 
with clinic staff. The chief barriers to pill-taking were food insecurity, stigma and discrimination.
Conclusion: The barriers to adherence are discussed. Attention is called to the extraindividual factors that influenced ART 
adherence. We conclude that contextual factors, such as a healthcare-enabling environment, might play an important role 
in influencing healthcare-promoting behaviour among patients. 
 Peer reviewed. (Submitted: 2011-12-07. Accepted: 2012-03-01.) © SAAFP  S Afr Fam Pract 2012;54(6)540-544
The perspectives of users of antiretroviral  
therapy on structural barriers to adherence in South Africa
Kagee A, PhD, MPH, Professor of Psychology
Nothling J, MA, Master’s Graduate
Coetzee B, MSc, Doctoral Student
Department of Psychology, Stellenbosch University
Correspondence to: Ashraf Kagee, e-mail: skagee@sun.ac.za
Keywords: adherence; antiretroviral therapy; structural barriers
Original Research: The perspectives of users of antiretroviral therapy on structural barriers to adherence
541 Vol 54 No 6S Afr Fam Pract 2012
Original Research: The perspectives of users of antiretroviral therapy on structural barriers to adherence
review of ART programmes in several African countries, 
these authors showed that suboptimal rates of adherence 
are common, and that adherence to care often declines 
significantly over time, prompting these authors to call 
for urgent research into the responsible factors for this 
phenomenon. A systematic review of patient retention 
in ART programmes in sub-Saharan Africa showed that 
approximately 60% of patients had remained in care after 
two years of treatment.7 In this review of 32 studies that 
reported on a total of over 74 000 patients in 13 countries, 
loss to follow-up accounted for most attrition, leading the 
authors to call for better patient-tracing procedures and 
a better understanding of loss to follow-up and earlier 
initiation of ART, as ways to improve retention of patients 
in care.
Individual, psychological and behavioural factors have 
been identified as barriers to adherence.8 These include 
treatment side-effects and poor health literacy,9 lack of 
social support,10 poor mental health,11 substance abuse,12 
stigma and discrimination,13 and treatment efficacy.14 Less 
attention has been given to structural barriers to adherence. 
These are the political, economic and environmental factors 
that reduce the likelihood of access to health care and that 
negatively influence pill-taking behaviour.15 
Structural barriers can be divided into three categories, 
namely poverty-related barriers, institution-related barriers 
and political and cultural barriers. Poverty-related barriers 
include the costs and circumstances associated with 
travelling to the clinic,5 food insecurity,5 loss of wages,16 
disincentives associated with disability grants17 and lack 
of social support.18 Institution-related barriers include 
overburdened healthcare facilities,19 inadequate access 
to mental healthcare facilities20 and insufficient numbers 
of adherence counsellors.21 Political and cultural barriers 
include political controversies such as AIDS denialism 
and disputes about the effects of ART,17 migrant labour,18 
traditional convictions,19 health illiteracy9 and stigma.10 The 
present qualitative study sought to document South African 




All participants were HIV positive, were enrolled in the 
national ART programme and received their medication 
from a hospital in the Western Cape region of South Africa. 
The final sample consisted of 10 patients; seven men and 
three women, aged 22-37. The patients were all black South 
Africans, who were either unemployed or employed part-
time in the informal sector. All reported that they were poor. 
They were recruited via a nongovernmental organisation 
(NGO) that provides psychosocial support services to ART 
users. The NGO identified that these patients had difficulty 
with adherence. Patient advocates, who were laypersons 
who assisted patients with adherence, also helped with 
sample recruitment. 
Ethics procedures
Ethics approval was obtained from the Health Research 
Ethics Committee of Stellenbosch University and the 
Western Cape Department of Health. The names of the 
respondents were changed to ensure their anonymity.
Interview procedure 
Semi-structured interviews were conducted with 
participants, the purpose of which was to obtain a rich 
narrative that would be suitable for qualitative data analyses. 
A standard interview schedule was used that contained 
open-ended questions, as well as follow-up probes. These 
interviews were conducted by the lead researcher who had 
considerable experience in qualitative interviewing. The 
interviews proceeded until saturation point was reached. 
The interviews were conducted in a private room under 
confidential conditions. On completion of the interview 
procedure, participants received a grocery voucher as a 
token of appreciation for their time. 
Data analysis
The interviews were recorded, transcribed and imported 
into Atlas.ti 4.2®, a computer programme that assists 
researchers with the analysis and interpretation of large 
quantities of textual information. The programme enables 
researchers to select, code, annotate and compare 
important segments of the text. 
Results
Table I presents a summary of the study findings. These 
are divided into poverty-related barriers, institution-related 
barriers and social barriers. 
Poverty-related barriers to clinic attendance
Time away from work 
Patients reported that they were often absent from work for 
a whole day, because of the large number of patients and 
long waiting times at clinics. 
Table I: Key barriers as they related to adherence to care and 
pill-taking
Adherence to care Adherence to pill-taking
Poverty-related barriers
Time away from work Food insecurity
Travel expenses and distance
Institution-related barriers
Long waiting times
Negative experiences with clinic 
staff
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A female participant, Laura, explained: 
“...when I was still working and I had to come to the clinic 
for my appointment, I had to ask for a day’s leave in order to 
go to the clinic....” 
Patients reported that their absence from work often meant 
losing a day’s wage, given their conditions of work. Such 
conditions often proved prohibitive for many patients when 
considered in the context of their living expenses. This 
resulted in their choice to go to work, rather than attend 
clinic appointments.
Travelling costs, distance and personal safety 
Travel expenses and distance were major barriers to 
adherence. Participants indicated that they used public 
transport, particularly minibus taxis, which were expensive 
and in some cases not affordable. 
Greg, a 39-year-old patient, said:
“I’m stressed, especially in the mornings when I know it’s my 
date to go to the hospital and I have no money. I have to see 
the doctor... then I have to walk, because there is no money 
and the taxi fee is ten rand, ten rand!” 
Another patient, Jane, reported that she had walked three 
hours to the hospital and had already terminated her 
treatment once. She stated:
“I don’t think I will be able to walk to the hospital anymore, 
because it is takes a lot of time walking to the hospital and 
it makes you very tired and it even makes you feel sick, 
because it is very hot.” 
The issue of risk to personal safety also emerged as an 
important factor. Patients reported that they often needed 
to walk to the clinic in the dark in order to arrive early in the 
morning. They were concerned about their personal safety, 
given the high rate of crime in the communities in which 
they lived. 
Greg described his experience in the following manner: 
“I have to cross that busy road and then I have to walk past 
(name of township) and the people there are violent. I can 
only thank the Lord if I arrive safely at the hospital and from 
the hospital to my home.” 
The problems that patients experienced regarding 
transport, distance and security were disincentives to clinic 
attendance and thus to adequate HIV care.
Poverty-related barriers to pill-taking
Food insecurity 
One of the main barriers to pill-taking identified by patients 
was food insecurity. Several patients indicated that they 
were often reluctant to take their medication on an empty 
stomach because of related side-effects, such as nausea, 
vomiting and dizziness. 
Jennifer, a 32-year-old domestic worker, explained: 
“Sometimes there isn’t anything to eat, there isn’t always 
money, and sometimes there is no food in the house. You 
can’t take your medication on an empty stomach because 
you have to have something to eat in order to take your 
medication.” 
It has been noted that ART might increase the patient’s 
appetite and thus compensate for HIV-related weight loss.5 
Thus, maintaining a balanced diet, which is highly important 
for persons living with HIV, is made difficult due to living 
under conditions of poverty. 
Institution-related barriers to clinic attendance 
Long clinic waiting times 
Patients reported that the long waiting times at clinics were 
a disincentive to clinic attendance. They reported that they 
often spent an entire day at the clinic in order to see the 
doctor or nurse for an appointment that lasted only a few 
minutes. 
Edward, a 23-year-old man, indicated that attendance of 
clinic appointments was a problem for him, because of the 
long waiting hours. He said: 
“There are too many people there. Sometimes you wait 
three or four hours and then they just weigh you, then you 
have to wait again until they call you and then you can see 
the doctor and then you have to wait again.” 
Reports of this nature by the other participants were 
common. 
Experiences with clinic staff 
Patients reported that they found nursing staff to be 
unsympathetic and rude towards them. They reported that 
they felt unwelcome at the clinic and alienated from the 
healthcare system. This made them reluctant to attend the 
clinic. 
Jennifer shared her experience: 
“… there are a lot of grumpy nurses. Their attitude isn’t what 
it’s supposed to be. A nurse once asked me why I was so 
late. Then I told her that I can’t help it, I don’t have transport, 
I walk to the hospital, I don’t have money...then she said to 
me that I would just have to wait till she decides if she wants 
to help me.” 
Jennifer’s quotation epitomised the experiences of several 
patients who felt that nursing staff members were indifferent 
to them, and sometimes even hostile.
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Access to substance abuse treatment programmes 
Several participants stated that substance abuse created 
problems for them. 
Michelle, a 28-year-old patient, said that previously alcohol 
abuse used to impede her ability to adhere to ART. She said: 
“I also used to drink and then I would forget to take my 
medication, I didn’t care.” 
This experience was typical for other patients, who shared 
similar experiences. Michelle also spoke of the difficulty 
that she experienced in accessing treatment for her alcohol 
problem. This was reflected in others’ experiences as well. 
While substance abuse was a psychosocial or medical 
matter for patients, the absence of available substance 
abuse treatment programmes was considered to be a 
structural barrier to ART adherence.
Social barriers to clinic attendance
HIV-related stigma 
Participants indicated that stigma was a major problem in 
their families and the community, to the extent that they 
were reluctant to disclose their HIV-positive status to friends 
and family members. 
Marcia, a 25-year-old patient, said: 
“The community is very small, it (gossip) goes around. It’s 
not only the neighbours, it is everyone. If you start a small 
fire, then the whole field is burning, the way they go on.” 
Another patient, Jessica, confirmed Marcia’s experience 
of stigma: “...and my friends, I haven’t told them.… I don’t 
tell them about it, because they will make it a problem. 
Tomorrow, the story will spread in every direction. That is 
why I will never tell them.” 
The stigmatised nature of HIV was closely associated 
with adherence, as patients were deprived of a significant 
source of social, instrumental and financial support that 
would facilitate clinic attendance and responsible pill-taking 
behaviour. Participants who had disclosed their status to 
family members or friends indicated they often reminded 
them to take their medication, assisted with transport costs 
and encouraged them to attend clinic appointments. 
Participants said that they found it difficult to take their 
medication in front of family members who were unaware of 
their status. Some of the participants lived in overcrowded 
conditions with limited privacy due to poverty. This made 
it difficult for them to store and consume their medication 
without family members noticing. 
James, a 20-year-old participant, described his living 
conditions in the following manner: 
“At the moment there are five of us in the bungalow and it 
is a wooden structure. It is very small, and there is only a 
big bed in the room in the bungalow, and all of us sleep on 
the bed.” 
James went on to describe how he needed to hide the fact 
that he was receiving ART, to the extent that he sometimes 
did not take his medicine if he thought that someone might 
see him.
The combination of poverty-related barriers, institution-
related barriers and social barriers proved challenging for 
the patients who participated in the study and accessed 
their treatment from the public healthcare system. 
Discussion
The study sought to identify the chief structural barriers to 
adherence from the perspective of patients receiving ART. 
Overwhelming data on HIV incidence and prevalence in sub-
Saharan Africa indicate that the disease is more common 
among the poor. Thus, in addition to the disproportionate 
distribution of the disease among economically 
impoverished persons, adherence is also made more 
difficult by living in poverty.
The data that emerged in the context of the research 
indicated that structural factors affected adherence at 
two levels. One was clinic attendance, which can be 
referred to as adherence to care. The other was actual pill-
taking behaviour, which can be referred to as medication 
adherence. These two levels of adherence relate to each 
other and are inseparable. 
In the context of widespread unemployment in South 
Africa, long waiting times create reluctance on the part of 
patients to take time off work to attend clinic appointments. 
In situations in which unskilled and semi-skilled seasonal 
and contract work, rather than permanent employment is 
common, the likelihood of retaining constant employment 
is tenuous at best. This creates a disincentive to attend 
appointments, especially when this requires the commitment 
of several hours that might be spent working and earning 
money instead. In addition, patients who are reluctant to 
disclose their HIV-positive status and who decide not to 
indicate their need for medical treatment to their employers, 
don’t benefit from sick benefits, including time off work to 
attend appointments. 
The issue of patients’ physical safety as members of the 
general public also related to living under impoverished 
conditions. Income inequality is among the highest in 
the world in South Africa.22 Poor South Africans bear a 
differential burden of social problems, one of which is violent 
crime. Most ART users who seek services from the public 
healthcare system live under impoverished conditions, 
which are simultaneously characterised by high levels of 
community violence. While seeking healthcare services, 
their physical safety is often uncertain. This creates an 
additional barrier to service utilisation. 
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Similarly, the level of efficiency of the South African 
healthcare system is a function of the two-tiered nature 
of health care in the country, namely private and public. 
Usually, patients receiving private health care have medical 
insurance, are employed and have a greater level of financial 
security than those who utilise the public healthcare system. 
Generally, those who make use of services in the public 
healthcare system do so because they are unable to afford 
private health care, which, without health insurance, is often 
prohibitively expensive. 
In general, public health care in South Africa is often 
underfunded. Insufficient funds are directed at hiring nursing 
staff. Therefore, because of large patient numbers, many 
patients face the phenomenon of long waiting times, which 
serves as a disincentive to their clinic attendance. In the 
context of competing demands on their time, particularly 
work commitments, as discussed previously, and 
personal concerns such as child care needs and those of 
stigmatisation if services for AIDS-related health concerns 
are sought, many patients decide against clinic attendance. 
This results in potential defaulting.
Because of high patient numbers,21 staff burnout is likely 
to occur. The experience of patients as they interact 
with overwhelmed staff is important to consider, as it is 
at this nexus that adherence and other health-related 
decision-making occurs. As positive relationships between 
healthcare staff and patients predict adherence levels,23 
in a situation in which such a positive relationship does 
not occur, adherence is likely to be suboptimal. Transport 
expenses and long waiting times, combined with negative 
experiences with nursing staff, many of whom experience 
burnout, create strong disincentives for clinic attendance.
HIV-related stigma is an ongoing feature of the AIDS 
pandemic worldwide. Many ART users prefer to seek 
services at clinics far from their homes to avoid being 
seen by members of their community. Transport expenses 
and difficulties constitute barriers to clinic attendance.24 
In addition to clinic attendance, stigma also affects pill-
taking behaviour. Patients whose family members do not 
know of their HIV-positive status sometimes have to hide 
their medication and conceal their pill-taking behaviour so 
as not to arouse suspicion that they are living with HIV.16 
Together, these conditions create strong societal and social 
disincentives to adherent behaviour. 
Strengths and limitations of the study
The use of qualitative research methods allowed for detailed 
descriptions of patients’ perspectives on barriers to ART 
adherence. The small sample size, although appropriate 
for qualitative research, means that the research is not 
generalisable. Another limitation of the study was language, 
as interviews were conducted in Afrikaans or English, 
yet many patients were Xhosa-first-language speakers. 
Patient advocates acted as interpreters when necessary 
to minimise this limitation. Additional studies of this nature 
should be conducted in the home language of respondents 
so as to arrive at more nuanced perspectives of their 
experiences. This study identified key structural barriers to 
ART adherence from the perspective of patients. As such, 
it represents the way in which patients, as individuals, 
encounter and interact with the social and economic 
context in which they find themselves.
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